secwatch.observer — SEC 8-K summary
======================================

Issuer:     DLH Holdings Corp. (DLHC)
CIK:        0000785557
Form:       8-K
Filed at:   2026-05-06T23:59:59+00:00
Accession:  0001628280-26-031338
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DLH Q2 FY2026 net loss of $2.5M on revenue down 34%; backlog falls to $442.4M
-----------------------------------------------------------------------------

- Revenue $59.3M, down 33.5% YoY; net loss $(2.5)M vs income $0.9M; diluted EPS $(0.17) vs $0.06.
- Adjusted EBITDA $5.3M (9.0% margin) vs $9.4M (10.5% margin); free cash flow $3.8M vs $14.5M.
- Debt reduced to $132.7M from $136.6M at Q1 end; backlog $442.4M, down 14% from Sep 2025.
- Awarded 2-year sole source extension for NIH clinical research support contract.
- Management says legacy contract conversions to small businesses expected to complete in Q3 FY2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/785557/000162828026031338/0001628280-26-031338-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/785557/000162828026031338/dlhc-20260506.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-031338

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer